ENZO BIOCHEM INC Quarterly Cost of Revenue in USD from Q3 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Enzo Biochem Inc quarterly/annual Cost of Revenue history and growth rate from Q3 2021 to Q1 2024.
  • Enzo Biochem Inc Cost of Revenue for the quarter ending April 30, 2024 was $4.29M, a 4.18% decline year-over-year.
  • Enzo Biochem Inc Cost of Revenue for the twelve months ending April 30, 2024 was $17.2M.
  • Enzo Biochem Inc annual Cost of Revenue for 2023 was $17.9M, a 7.01% decline from 2022.
  • Enzo Biochem Inc annual Cost of Revenue for 2022 was $19.2M, a 70.1% decline from 2021.
  • Enzo Biochem Inc annual Cost of Revenue for 2021 was $64.2M, a 22.8% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $17.2M $4.29M -$187K -4.18% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-13
Q4 2023 $17.3M $4.33M -$287K -6.22% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-13
Q3 2023 $17.6M $4.35M -$238K -5.19% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-15
Q2 2023 $17.9M $4.19M +$34.1M May 1, 2023 Jul 31, 2023 10-K 2023-11-03
Q1 2023 -$16.3M $4.48M -$11.6M -72.1% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-13
Q4 2022 -$4.69M $4.62M -$13.2M -74.1% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-13
Q3 2022 $8.53M $4.59M -$10.7M -70% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 $19.2M -$29.9M May 1, 2022 Jul 31, 2022 10-K 2023-11-03
Q1 2022 $16M Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 $17.8M Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-20
Q3 2021 $15.3M Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.